Search research articles
Contact Us
Filters
Showing results (31-40 of 73) with videos related to
Page
of 8
Sort By:
Seminars in Oncology
|
October 1, 1995
The role of paclitaxel in the treatment of head and neck cancer
E E Vokes, D J Haraf, K Stenson, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique
|
August 14, 2003
[Prospective study of accelerated postoperative radiation therapy in patients with squamous-cell carcinoma of the head and neck]
A Zouhair, P A Coucke, D Azria, et al.
British Journal of Cancer
|
August 31, 2006
CPT-11 and concomitant hyperfractionated accelerated radiotherapy induce efficient local control in rectal cancer patients: results from a phase II
V Voelter, A Zouhair, H Vuilleumier, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
October 23, 2018
Leptomeningeal tumor response to combined MAPK/ERK inhibition in V600E-mutated gliomas despite undetectable CSF drug levels
A F Hottinger, D Bensaid, R De Micheli, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
July 1, 2016
Preoperative chemoradiotherapy with cisplatin and docetaxel for stage IIIB non-small-cell lung cancer: 10-year follow-up of the SAKK 16/01 trial
M Früh, H B Ris, A Xyrafas, et al.
Seminars in Oncology
|
June 1, 1995
Hydroxyurea with continuous infusion paclitaxel, 5-fluorouracil, and concomitant radiotherapy for poor-prognosis head and neck cancer
E E Vokes, R Stupp, D Haraf, et al.
Neurology
|
November 18, 2009
Bevacizumab for recurrent ependymoma
R M Green, T F Cloughesy, R Stupp, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))
|
September 10, 2005
A retrospective analysis of the outcome of patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck refractory to a platinum-based chemotherapy
X León, R Hitt, M Constenla, et al.
Nuklearmedizin. Nuclear Medicine
|
April 17, 2014
Combination of MRI and dynamic FET PET for initial glioma grading
V Dunet, P Maeder, M Nicod-Lalonde, et al.
European Journal of Cancer (Oxford, England : 1990)
|
July 2, 2002
Multicentre phase II and pharmacokinetic study of RFS2000 (9-nitro-camptothecin) administered orally 5 days a week in patients with glioblastoma multiforme
E Raymond, M Campone, R Stupp, et al.
Page
of 8
Search research articles
Search
Showing results (31-40 of 73) with videos related to
Sort By:
Page
of 8
Seminars in Oncology
|
October 1, 1995
The role of paclitaxel in the treatment of head and neck cancer
E E Vokes, D J Haraf, K Stenson, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique
|
August 14, 2003
[Prospective study of accelerated postoperative radiation therapy in patients with squamous-cell carcinoma of the head and neck]
A Zouhair, P A Coucke, D Azria, et al.
British Journal of Cancer
|
August 31, 2006
CPT-11 and concomitant hyperfractionated accelerated radiotherapy induce efficient local control in rectal cancer patients: results from a phase II
V Voelter, A Zouhair, H Vuilleumier, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
October 23, 2018
Leptomeningeal tumor response to combined MAPK/ERK inhibition in V600E-mutated gliomas despite undetectable CSF drug levels
A F Hottinger, D Bensaid, R De Micheli, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
July 1, 2016
Preoperative chemoradiotherapy with cisplatin and docetaxel for stage IIIB non-small-cell lung cancer: 10-year follow-up of the SAKK 16/01 trial
M Früh, H B Ris, A Xyrafas, et al.
Seminars in Oncology
|
June 1, 1995
Hydroxyurea with continuous infusion paclitaxel, 5-fluorouracil, and concomitant radiotherapy for poor-prognosis head and neck cancer
E E Vokes, R Stupp, D Haraf, et al.
Neurology
|
November 18, 2009
Bevacizumab for recurrent ependymoma
R M Green, T F Cloughesy, R Stupp, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))
|
September 10, 2005
A retrospective analysis of the outcome of patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck refractory to a platinum-based chemotherapy
X León, R Hitt, M Constenla, et al.
Nuklearmedizin. Nuclear Medicine
|
April 17, 2014
Combination of MRI and dynamic FET PET for initial glioma grading
V Dunet, P Maeder, M Nicod-Lalonde, et al.
European Journal of Cancer (Oxford, England : 1990)
|
July 2, 2002
Multicentre phase II and pharmacokinetic study of RFS2000 (9-nitro-camptothecin) administered orally 5 days a week in patients with glioblastoma multiforme
E Raymond, M Campone, R Stupp, et al.
Page
of 8